SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-054726
Filing Date
2021-11-05
Accepted
2021-11-05 06:51:19
Documents
84
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q syrs-10q_20210930.htm   iXBRL 10-Q 2753802
2 EX-10.2 syrs-ex102_32.htm EX-10.2 86153
3 EX-31.1 syrs-ex311_6.htm EX-31.1 17974
4 EX-31.2 syrs-ex312_8.htm EX-31.2 17936
5 EX-32.1 syrs-ex321_10.htm EX-32.1 5991
6 EX-32.2 syrs-ex322_9.htm EX-32.2 5937
7 GRAPHIC g5twfp1r20vw000003.jpg GRAPHIC 4983
8 GRAPHIC g5twfp1r20vw000001.jpg GRAPHIC 6684
9 GRAPHIC g5twfp1r20vw000002.jpg GRAPHIC 6965
  Complete submission text file 0001564590-21-054726.txt   10619977

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA syrs-20210930.xsd EX-101.SCH 72138
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syrs-20210930_cal.xml EX-101.CAL 63970
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syrs-20210930_def.xml EX-101.DEF 254596
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE syrs-20210930_lab.xml EX-101.LAB 538129
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syrs-20210930_pre.xml EX-101.PRE 449141
15 EXTRACTED XBRL INSTANCE DOCUMENT syrs-10q_20210930_htm.xml XML 2038370
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37813 | Film No.: 211382254
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences